At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Gastrisaildevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transmitted Light Tissue Thickness Analysis (TiLTT)
In Brief
A clinical study evaluating Gastrisail for Morbid Obesity. Completed, enrolled 10 participants across 1 site.
Detailed Summary
To assess gastric wall thickness using transmitted light intensity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMorbid Obesity
CountriesUnited States
CollaboratorsMedtronic
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionApr 2017
TodayJul 2026
First PostedApr 22, 2016
Enrollment StartApr 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 10.2 years ago
Interventions
Gastrisaildevice
Light Intensity and gastric wall thickness assessment